Kynam Capital Management »

Caribou Biosciences shares owned by Kynam Capital Management

Quarter-by-quarter ownership of Caribou Biosciences (CRBU) shares owned by Kynam Capital Management from 13F filings

Historical chart of Kynam Capital Management investment in Caribou Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Caribou Biosciences held by Kynam Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Caribou Biosciences by Kynam Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.1M 1.1M 5.73
2023-09-30 $5.1M 1.1M 4.78

More positions owned by Kynam Capital Management

Natera (NTRA)
Syndax Pharmaceuticals (SNDX)
Celldex Therapeutics Com New (CLDX)
Vaxcyte (PCVX)
Vera Therapeutics Cl A (VERA)
Protagonist Therapeutics (PTGX)
ImmunoGen
Morphosys Sponsored Ads (MOR)
Cogent Biosciences (COGT)
Liquidia Corporation Com New (LQDA)
BioCryst Pharmaceuticals (BCRX)
2seventy Bio Common Stock (TSVT)
Dynavax Technologies Corp Com New (DVAX)
Wave Life Sciences SHS (WVE)
Corcept Therapeutics Incorporated Put Option (CORT)

View all positions for Kynam Capital Management

Top funds holding Caribou Biosciences

Partner Fund Management
Avidity Partners Management
Vanguard Group
Point72 Asset Management
Paradigm Biocapital Advisors
Elmwood Wealth Management
Bank of America Corporation
Dimensional Fund Advisors
Kynam Capital Management
Candriam Luxembourg S.C.A.
Rokos Capital Management
Charles Schwab Investment Management
Goldman Sachs Group
Maverick Capital
Jpmorgan Chase & Co

View all funds holding Caribou Biosciences